Transforming_growth_interacting_factor References

From Wikipedia, the free encyclopedia

Transforming growth interacting factor (TGIF) is a potential repressor of TGF-β pathways in myometrial cells.^[1] Expression of TGIF is increased in uterine leiomyoma compared with myometrium.^[1]

References

^ ^a ^b Yen-Ping Ho J, Man WC, Wen Y, Polan ML, Shih-Chu Ho E, Chen B (June 2009). "Transforming growth interacting factor expression in leiomyoma compared with myometrium". Fertil. Steril. 94 (3): 1078–1083. doi: 10.1016/j.fertnstert.2009.05.001. PMC 2888713. PMID 19524896.

Cell signaling: TGFβ signaling pathway

TGF beta superfamily of ligands

Ligand of ACVR or TGFBR	TGF beta family TGF-β1 TGF-β2 TGF-β3 Activin and inhibin INHA INHBA INHBB INHBC Nodal
Ligand of BMPR	Bone morphogenetic proteins BMP2 BMP3 BMP4 BMP5 BMP6 BMP7 BMP8a BMP8b BMP10 BMP15 Growth differentiation factors GDF1 GDF2 GDF3 GDF5 GDF6 GDF7 Myostatin/GDF8 GDF9 GDF10 GDF11 GDF15 Anti-müllerian hormone

TGF beta receptors
( Activin, BMP, family)

TGFBR1:	Activin type 1 receptors ACVR1 ACVR1B ACVR1C ACVRL1 BMPR1 BMPR1A BMPR1B
TGFBR2:	Activin type 2 receptors ACVR2A ACVR2B AMHR2 BMPR2
TGFBR3:	betaglycan

Transducers/ SMAD

Ligand inhibitors

BAMBI
Cripto

Other

SARA

TGFβ receptor superfamily modulators

ALK1 ( ACVRL1)	Agonists: Activin ( A, B, AB) Avotermin BMP ( 10) Cetermin GDF ( 2 (BMP9)) TGFβ ( 1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide
ALK2 ( ACVR1A)	Agonists: Activin ( A, B, AB) AMH (MIS) Avotermin BMP ( 5, 6, 7, 8A, 8B) Eptotermin alfa TGFβ ( 1, 2, 3) Kinase inhibitors: DMH-1 DMH-2 Dorsomorphin (BML-275) K-02288 ML-347 (LDN-193719, VU0469381)
ALK3 ( BMPR1A)	Agonists: AMH (MIS) BMP ( 2, 4, 5, 6, 7, 8A, 8B) Dibotermin alfa Eptotermin alfa Kinase inhibitors: DMH-2 Dorsomorphin (BML-275) K-02288
ALK4 ( ACVR1B)	Agonists: Activin ( A, B, AB) GDF ( 1, 3, 11 (BMP11)) Myostatin (GDF8) Nodal Antagonists: Inhibin ( A, B) Lefty ( 1, 2) Kinase inhibitors: A 83-01 SB-431542 SB-505124
ALK5 ( TGFβR1)	Agonists: Avotermin GDF ( 10 (BMP3B), 11 (BMP11)) TGFβ ( 1, 2, 3) Antibodies: Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761 Galunisertib (LY-2157299) R-268712 RepSox (E-616452, SJN-2511) SB-431542 SB-505124 SB-525334 SD-208
ALK6 ( BMPR1B)	Agonists: BMP ( 2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B)) Dibotermin alfa Eptotermin alfa GDF ( 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15) Radotermin Kinase inhibitors: DMH-2 Dorsomorphin (BML-275) K-02288
ALK7 ( ACVR1C)	Agonists: GDF ( 1, 3, 11 (BMP11)) Nodal Antagonists: Lefty ( 1, 2) Kinase inhibitors: A 83-01 SB-431542 SB-505124

TGFβR2	Agonists: Avotermin GDF ( 10 (BMP3B)) TGFβ ( 1, 2, 3) Antibodies: Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: DMH-2 LY-364947
BMPR2	Agonists: BMP ( 2, 4, 6, 7, 10) Dibotermin alfa Eptotermin alfa GDF ( 2 (BMP9), 5 (BMP14), 6 (BMP13), 7 (BMP12)) Radotermin Antagonists: Inhibin ( A, B)
ACVR2A ( ACVR2)	Agonists: Activin ( A, B, AB) BMP ( 2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B)) Dibotermin alfa Eptotermin alfa GDF ( 1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15) Myostatin (GDF8) Nodal Radotermin Antagonists: Inhibin ( A, B) Lefty ( 1, 2) Decoy receptors: Sotatercept
ACVR2B	Agonists: Activin ( A, B, AB) BMP ( 2, 4, 6, 7) Dibotermin alfa Eptotermin alfa GDF ( 1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12)) Myostatin (GDF8) Nodal Osteogenin (BMP3, BMP3A) Radotermin Antagonists: Inhibin ( A, B) Lefty ( 1, 2) Decoy receptors: Ramatercept
AMHR2 ( AMHR)	Agonists: AMH (MIS)

TGFβR3 (β-glycan)	Ligands: Avotermin Inhibin ( A, B) TGFβ ( 1, 2, 3)

Unsorted

Endogenous antagonists/inhibitors: BAMBI
Cerberus (CER1)
Chordin
DAN (PARN)
Decorin
Follistatin
Gremlin (Drm)
LTBP1
Noggin
TGIF
Thrombospondin 1 (THBS1)
Tomoregulin 1

Antibodies: Stamulumab (against myostatin)
TRC105 (against endoglin)

Others: Endoglin

Retrieved from " https://en.wikipedia.org/?title=Transforming_growth_interacting_factor&oldid=992958973"

TGFβ domain